Abstract-This paper reports the application of endoscopic light scattering spectroscopy (LSS) with light gating to detect malignancies in the biliary and pancreatic ducts, and also reviews the application of endoscopic LSS for differentiating cystic neoplasms in the pancreas and detecting invisible dysplasia in Barrett's esophagus. Information about tissue structure within the superficial epithelium where malignancy starts is present within the spectra of reflected light. Fortunately this component of the reflected light is not yet randomized. However multiple scattering randomizes the signal from the underlying connective tissue which obscures the desired signal. In order to extract diagnostic information from the reflected signal the multiple scattering component related to connective tissue scattering and absorption must be removed. This is accomplished using described here spatial or polarization gating implemented with endoscopically compatible fiber optic probes.
I. INTRODUCTION

S
PECTRA of light reflected from tissue in the gastrointestinal tract depend strongly on the elastic scattering from the connective tissue fibers and extracellular matrix and on hemoglobin absorption in the capillary network. However, to reach connective tissue, light has to penetrate the superficial cellular layer called epithelium, which lines both outer and inner surfaces of organs throughout the body. Intracellular structures with sizes smaller than optical wavelengths are responsible for the larger part of the epithelial scattering signal, with the component from epithelial cell nuclei also present. Relative contribution of the nuclear component is increasing in the backscatter direction. As enlarged, crowded, and dense epithelial cell nuclei are the primary histological features of pre-cancer and cancer, a technique which relates the spectroscopic characteristics of light reflected from tissue to epithelial cell nuclear morphology can be used for pre-cancer diagnosis. Such a technique is called biomedical light scattering spectroscopy, or LSS [1] , [2] .
As light propagates through tissue, multiple scattering events randomize information about the tissue structure. However, within the superficial epithelium, where malignancy starts, the light is not yet randomized. In order to extract the diagnostic information from the reflected signal the multiple scattering component related to the connective tissue scattering and absorption needs to be removed. This can be accomplished by several light gating approaches [3] , with polarization gating and spatial gating well suited for endoscopy applications [4] - [7] .
Polarization gating employs the fact that light scattered back from the epithelial cells located at the surface retains the incoming polarization, whereas multiple scattering from the deeper tissue regions is depolarized (see Fig. 1(a) ). Subtracting parallel and perpendicular signals cancels the deeper tissue effect. The result is then due only to the contribution of the epithelial cells [4] - [6] .
Spatial gating utilizes the fact that contribution of light scattered from the superficial layers increases with the decrease in source-detector significantly faster than that scattered from the deeper tissue regions. Therefore, by collecting light signals at two different small source-detector separations and subtracting these signals with appropriate weighting coefficients, contribution from deeper tissue regions can be canceled. The result is once again related to the contribution of the epithelial cells [7] . Epithelial tissue is illuminated with polarized light emitted from the polarized scanning fiber optic probe. The backscattered light from the cells in the superficial layer of epithelium is polarized parallel to the incoming light, while the light reflected from the deeper tissues becomes depolarized, containing equal amounts of parallel and perpendicular polarizations. Subtracting the two polarizations cancels out the contribution of deeper tissues and the resulting signal is proportional to the signal from the epithelium, which contains the information about early precancerous changes. (b) Spatial gating. Epithelial tissue is illuminated with the left fiber while two other fibers collect backscattered light at very small source-detector separations. Subtraction of signals collected by those fibers with the appropriate weighting coefficients cancels contribution from deeper tissue regions, with the result related to the contribution of the epithelial cells.
In this paper, we describe the use of LSS with both techniques of light gating for early cancer detection in several organs of the gastrointestinal tract. Each of these applications requires the use of endoscopy and, therefore, an endoscopic LSS clinical instrument and several fiber optic gating probes have been developed. The paper reviews the application of endoscopic LSS for diagnosing dysplasia in Barrett's esophagus, differentiation of cystic neoplasms in the pancreas, and reports new results of detecting dysplasia and malignancy in the biliary and pancreatic ducts.
II. LIGHT GATING LSS FIBER OPTICS PROBES
The endoscopic LSS clinical instrument compatible with polarization and spatial light gating is shown in Fig. 2 . A multichannel spectrometer, broadband bright LED light source, and power supply are installed in the bottom part of the case (see Fig. 2(b) ). A computer for system control is also located in the bottom part of the case and is used for data analysis and visualization of the diagnostic information. The middle shelf houses fiber connector for light delivery connected to the light source and two fiber connectors for light detection connected to two spectrometer channels. This shelf also houses the probe control box (Fig. 2(c) ) employed when the instrument is used in combination with the polarization gating scanning fiber probe. In that case the spectrometer channels are connected to the parallel and perpendicular polarization fibers of the polarization gating fiber probe. This easily accessible middle shelf is also used for the safe storage of the probes. A hinged door installed on the side wall of the case allows convenient extension of the probe from the case for its insertion in the working channel of the commercial endoscope, without the need to disconnect and reconnect the probe. The upper shelf of the instrument has a built in keyboard, mouse and a slot for probe calibration. The slot provides probe access to a light-tight enclosure housing an attached Spectralon reflectance standard. The case's cover houses a flat touch screen.
The instrument employs either polarization or spatial gating probes. Polarization gating is well suited for rapid non-contact scanning of large epithelial surfaces, such as esophageal or colonic wall, and requires the probe to be inserted into the working channel of an endoscope, ranging from 2.0 to 4.2 mm [8] . Therefore, these type of probes can afford more complex optics which includes polarizers, mirrors, and lenses. At the same time, certain applications in the gastrointestinal tract require fitting the probe into very tight sub-millimeter spaces, such as a 1.2 mm cholangiopancreatoscopy system working channel or even a 0.5 mm internal diameter aspiration needle. Here spatial gating, which can be implemented in a much more compact package, is the way to go. The polarization gating scanning fiber probe is presented in Fig. 3(a) . Here a 400 µm core delivery fiber (NA = 0.22) is attached to a 200 µm thick, 1.5 mm diameter cylindrical linear polarizer/analyzer with two orthogonal polarization components. The delivery fiber is adjacent to two 200 µm core collection fibers (NA = 0.22), each behind a linear polarizer which is shaped to ensure that one fiber collects light with the same polarization as the delivery fiber and the other collects perpendicularly polarized light. It is necessary to mount the polarizers at the distal tip since multimode fibers do not maintain polarization. At the probe distal tip a parabolic mirror collimates the illumination beam and collects light from the 2 mm illuminated spot. This compensates for peristaltic and other motions of the esophagus or other GI organ. Collimation ensures that the spectrum is not affected by distance or orientation. In the esophagus for instance, gentle air insufflation of the gastrointestinal lumen helps maintain a relatively stable tubular shape and prevents the optical probe from touching the esophageal walls. However, even if the probe comes in contact with the wall, the overlap of the illumination and collection fields at the probe window is 75% which is adequate for evaluating the backscattering component. With the increase of the distance the overlap is also increasing and becomes optimal at 11 mm distance from the axis of the probe, although the degree of overlap remains adequate up to approximately 20 mm from the probe axis. To avoid specular reflection, light is directed approximately 70°to the axis of the probe. The probe is protected by the parylene coated stainless steel torque tube connected to two stepper motors of the control box, providing rotary and axial scanning. To increase scanning accuracy the data collection is performed only during the counterclockwise rotational scan. After the data collection is complete, the probe rotates 1.25 revolutions clockwise and then 0.25 revolution counterclockwise to minimize hysteresis of the torque tube and ensure the same angular position for the start of the next rotational scan.
The 450 µm outer diameter spatial gating fiber probe is presented in Fig. 3(b) and consists of seven 100 µm core diameter fibers (NA = 0.21). A fiber in the outer ring of the probe is selected as the delivery fiber and is connected to a dedicated SMA connector, while three groups of collection fibers are selected to provide source-detector separations of 120, 220 and 240 µm and are terminated in three SMA connectors coupled to individual spectrometers. All of the fiber trunks are connected to a metal ferrule. The probe jacket is made of a robust medical grade biocompatible polyimide.
We used multispectral endoscopy with light gating to detect dysplasia in Barrett's esophagus, pancreatic cystic neoplasms, and malignancy of biliary and pancreatic ducts (see Fig. 4 ). In the case of Barrett's esophagus, a polarization gating scanning fiber probe is inserted directly into the working channel of a standard gastroscope. In order to evaluate a pancreatic cyst, or the biliary and pancreatic ducts, the spatial gating fiber probes are inserted in the endoscopic ultrasound aspiration needle, or a cholangiopancreatoscopy system respectively, which in turn are inserted into the working channel of either an echoendoscope or standard gastroendoscope. The details of each of those studies are found below.
III. DYSPLASIA IN BARRETT'S ESOPHAGUS
Esophageal cancer is increasing in frequency in the United States faster than any other cancer. Barrett's esophagus, a precancerous complication of esophageal reflux, affects approximately three million Americans and precedes almost all cases of esophageal cancer. In cases when Barrett's esophagus progresses to higher risk 'high-grade dysplasia', it can be definitively treated to prevent esophageal cancer. However, dysplasia may not be detected by standard-of-care screening endoscopy which uses visual endoscopy and a prescribed pattern of biopsy. This procedure, in which a tiny fraction of the affected tissue is selected for pathological examination, has a low probability of dysplasia detection because dysplasia is highly focal and is often not distinguishable by endoscopic appearance alone.
Several new imaging approaches have been explored clinically to visualize dysplasia: high resolution endoscopy (HRE) combined with narrow band imaging (NBI) [9] , autofluorescence imaging (AFI) [10] , trimodal imaging [11] , which is a combination of the previous three, confocal laser endomicroscopy (CLE) [12] , and optical coherence tomography (OCT) [13] - [15] . These techniques showed promise in increased detection of dysplasia in Barrett's esophagus, and are used at specialized referral centers, but are not yet part of routine clinical practice.
A clinically viable dysplasia detecting technique in Barrett's esophagus has to overcome the challenge of combining conflicting goals of (1) macroscopic large area imaging and (2) microscopic subcellular sensitivity. Our approach achieves both by combining (1) rapid endoscopically compatible scanning of the entire esophageal surface with (2) LSS that uses polarization gating to remove the contribution of the deeper tissues.
To date we have employed the endoscopic LSS clinical instrument in 76 Barrett's esophagus subjects at the Center for Advanced Endoscopy These evaluations were performed during routine endoscopic procedures for patients with suspected dysplasia and individuals undergoing radiofrequency ablation (RFA) or cryoablation treatment of Barrett's esophagus for histologically confirmed high grade dysplasia. The 57 subjects from the first group reporting to the Center for Advanced Endoscopy underwent initial screening at other institutions and were referred with confirmed Barrett's esophagus and suspicion of dysplasia. In the treatment group, confirmatory biopsies had typically already been obtained, and patients were beginning endoscopic treatment. Therefore, in the first group endoscopic biopsies were collected according to the standard-of-care protocol [16] , while in the second group of 19 subjects, in which biopsy diagnoses had been made previously, and the endoscopic procedure was focused on treatment [17] , repeat biopsies were not obtained the LSS data was retained for the future longitudinal study of treatment efficacy.
During endoscopy spectroscopy of the entire Barrett's segment is performed by scanning adjacent sections, 2 cm in length, with the polarized scanning probe. The probe is extended 2 cm beyond the endoscope tip, placing it at the distal boundary of a Barrett's esophagus region chosen for examination. One complete rotary scan, collecting 30 data points on the esophageal wall, is completed followed by a linear 2 mm backward withdrawal into the endoscope. This is repeated for 10 rotary scans, so that an entire 2 cm length of Barrett's esophagus is scanned; then, the endoscope tip is withdrawn 2 cm and the next length of BE is examined. 300 data points in 30 sec for each 2 cm segment of Barrett's esophagus are collected.
We validated the capabilities of the method by comparing the LSS data with subsequent pathology at each site where biopsies were taken. We recorded the locations of biopsied tissue sites by their distances from the upper incisors and their angles relative to the start of the LSS scan. The results are presented as pseudocolor maps (see Fig. 5(a) ).
The performance of LSS with polarization light gating was evaluated in two separate double-blind studies, emphasizing (1) biopsy based diagnosis and (2) patient based diagnosis. The former approach, which characterizes the LSS potential for performing guided biopsy, is based on double-blind comparison of the LSS maps with the biopsy reports and identifying truepositive, false-positive, true-negative and false-negative sites for every biopsy location. The latter approach, which characterizes the LSS ability to serve as a screening tool, emphasizes identifying presence of dysplasia in a particular Barrett's esophagus patient rather than localizing the dysplastic sites. The rationale for that approach is that at the moment radiofrequency ablation and cryoablation therapies are applied to the entire Barrett's esophagus segment, rather than specific sites where biopsies diagnosed as high-grade dysplasia were collected [17] .
The patient based diagnosis study is characterized by the sensitivity of 96% with a 95% confidence interval (CI) of 82-99% and the specificity of 97% (95% CI: 83-99%), exceeding the respective characteristics of 90% and 80% required by the American Society for Gastrointestinal Endoscopy (ASGE) for a new biopsy guidance technique to replace or supplement the current standard of care [18] .
A smaller biopsy based diagnosis study is characterized by a sensitivity of 88% (95% CI: 79-93%) and a specificity of 91% (95% CI: 87-93%) in detecting individual locations of high-grade dysplasia, with the area under the ROC curve (see Fig. 5(b) ) being 0.95 (95% CI: 93-97%). This means that when dysplasia is present in Barrett's esophagus, the LSS guided biopsy procedure has a 99.5% probability to locate it with just 4 guided biopsies, while the standard-of-care Seattle protocol has approximately 43% chance of detection with 20 biopsies [19] .
IV. PANCREATIC CYSTIC NEOPLASMS
Pancreatic cancer is the third leading cause of cancer-related death in the United States, surpassing breast cancer. With a median survival of three months it has the highest mortality rate of all major cancers [20] . The poor prognosis of pancreatic cancer is due in large part to the inability to detect this cancer at an early stage, when the option of a curative surgical resection is still possible [21] . About one fifth of pancreatic cancers arise from cystic lesions that can be discovered in early, treatable stages using non-invasive imaging techniques such as CT and MRI. However, not all pancreatic cystic lesions are precancerous, and differentiating between precancerous and benign cyst types is both crucially important and very difficult. It is estimated that 8 million Americans have pancreatic cystic lesions [22] , many being found incidentally during routine cross-sectional imaging in older adults. While CT and MRI could be used to screen for cystic lesions, they have poor accuracy with regard to distinguishing cancerous and pre-cancerous cysts from benign cysts. It should therefore come as no surprise that cystic lesions account for a disproportionate one third of all pancreatic surgeries [23] . The decision for surgical resection is usually based on crosssectional imaging results, in combination with the minimally invasive endoscopic ultrasound-guided fine needle aspiration (EUS-FNA). Unfortunately, cyst fluid often contains few cells, and fluid chemical analysis lacks accuracy. Misdiagnosis can lead to dire consequences, including the development of cancer in cysts thought to be benign, or unnecessary pancreatic surgery for benign cysts, often with significant morbidity and mortality. Thus, there is a critical need for a new diagnostic approach that accurately identifies those pancreatic cysts that require surgical intervention and those that do not.
We performed clinical measurements using endoscopic LSS instrument with spatial light gating on freshly resected pancreatoduodenectomy and distal pancreatectomy samples from 11 subjects, followed by in vivo measurements during routine EUS-FNA procedures in 14 consecutively enrolled subjects with pancreatic cysts. In total 27 cysts in 25 subjects were evaluated. To ensure proper co-registration with the subsequent histopathology examination in the measurements on freshly resected samples, the measured sites were marked with India ink, and photographed. To differentiate cystic neoplasms we employed the same diagnostic parameter used in Barrett's esophagus studies described in Section III, with cystic lesions with diagnostic parameter below 0.1 classified as benign, in the range from 0.1 to 0.2 as low-grade dysplasia, and above 0.2 as high-grade dysplasia and adenocarcinoma.
In vivo measurements using spatial gating LSS during routine EUS-FNA procedure were performed in 14 consecutively enrolled subjects with pancreatic cysts. Before the procedure, the spatial gating probe was inserted in the 22-gauge endoscopic ultrasound aspiration needle and secured with a fixed-length tube and probe latching mechanism to ensure that its distal end was completely inside the FNA needle. The subject was administered sedation and supplemental oxygen was used. The echoendoscope was introduced through the mouth and advanced to the stomach or duodenum. After pancreatic EUS examination, the FNA needle was inserted into the echoendoscope, and the cyst was punctured under ultrasound guidance. The spatial gating probe was then extended 2 mm beyond the tip of the needle with the probe latching mechanism and locked in that position with the locking button and multiple locations covering a portion of the forward hemisphere of the internal cyst surface were measured under EUS guidance. The total LSS measurement time was less than 2 minutes. The spatial gating probe was then removed, a 10 ml syringe was attached to the proximal end of the needle and the aspirated fluid was collected in the standard fashion. After the procedure, the aspirated fluid was sent for cytological and biochemical analysis.
The results of double-blind prospective study in 25 patients, with 14 cysts measured in vivo and 13 postoperatively are presented in Fig. 6 . The technique achieved an overall accuracy of 95%, with a 95% confidence interval of 78-99%, in cysts with definitive diagnosis. 
V. MALIGNANCY OF BILIARY AND PANCREATIC DUCTS
Bile duct cancer or cholangiocarcinoma is a relatively rare and lethal form of adenocarcinoma with most people having advanced stage, inoperable disease at presentation. Detecting cholangiocarcinoma at an early stage, when the option of a curative surgical resection is still possible, is a key priority in the field of gastroenterology.
We performed clinical measurements during endoscopic retrograde cholangiopancreatography (ERCP) procedures on patients with suspected dysplasia and malignancy of biliary and pancreatic ducts. When the duodenal papilla is located during endoscopy, a sphincterotome is inserted through the endoscope operating channel and guided through the papillary opening. A wire is then passed into the bile duct or pancreatic duct, and, when a concerning-appearing stricture was identified, standard brush cytology was performed to evaluate for malignancy. A smaller scope, called a cholangioscope, was then advanced over the wire and into the duct of interest. Then the spatial gating fiber-optic probe was inserted into the biliary or pancreatic duct through the cholangioscope working channel. When the probe is placed in contact with the tissue, a set of three spectra are collected and stored for future processing. Biopsies were taken at the same locations, with cholangiopancreatoscopy system video ( Fig. 7(a) ) and X-ray cholangiogram video (Fig. 7(b) ) used to ensure co-registration of the spectroscopy and biopsy locations.
We collected spectra from 24 sites in pancreaticobiliary system in 6 patients. Fig. 7(c) shows mean reflectance spectra and standard deviations for normal, inflammatory, and dysplastic sites, as reported by pathology, for 120 µm source-detector separation of the fiber probe. The spectra show clear differentiation between dysplasia (red), inflammation (blue) and normal (green) sites. By taking into account all three source-detector separations for each of the sites we modeled the spectra and extracted four morphological and biochemical tissue parameters: effective scatterer size and effective scatterer density, hemoglobin concentration, and hemoglobin oxygen saturation, The model fits were excellent, as can be seen from three typical fits, presented in Fig. 7(d) for each of the three pathology diagnosis. From four parameters employed by the model, two -hemoglobin concentration (Fig. 7(e) ) and effective scatterer size (Fig. 7(f) ) -appear to provide the best differentiation between sites. This makes sense taking into account the onset of the angiogenesis and changes in the cellular morphology, typical of dysplastic transformation in epithelial tissues.
VI. CONCLUSION
We conclude that multispectral endoscopy with light gating offers great promise for detecting precancerous and early cancerous conditions in various organs of the gastrointestinal tract. For organs with large epithelial surfaces, such as the esophagus, polarization gating provides rapid non-contact interrogation of the entire epithelial area. For organs located deep in the abdomen which are difficult to access, spatial gating, which can be implemented in a much more compact package, is the preferred approach. Multispectral endoscopy with light gating is rapid, inexpensive, and accurate. We have shown that this technique can help identify early precancerous lesions and early cancers of the GI tract accurately. This approach may enable earlier and more effective treatments for patients with these conditions, and may also reduce the risk of unnecessary surgery for benign lesions.
